SCHEMBL9983004

SCHEMBL9983004

[C]1=COC=C(c2cccnc2)O1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 6/20 0.47
ALDH1A1 P00352 4/20 0.47
CYP3A4 P08684 3/20 0.47
CYP1A2 P05177 1/20 0.47
CHRNB2 P17787 2/20 0.45
CHRNA5 P30532 2/20 0.45
CHRNA4 P43681 2/20 0.45
TP53 P04637 5/20 0.42
SMN1; SMN2 Q16637 5/20 0.42
KDM4E B2RXH2 2/20 0.41
MAPT P10636 2/20 0.41
HPGD P15428 2/20 0.41
HSD17B10 Q99714 2/20 0.41
LMNA P02545 1/20 0.41
ALOX15 P16050 1/20 0.41
HTT P42858 1/20 0.41
PPARA Q07869 3/20 0.41
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
CYP2E1 P05181 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL513742 0.71 ALDH1A1 (0.50) CYP2A6ALDH1A1CYP3A4CYP1A2CHRNB2
SCHEMBL30473120 0.67 CYP2A6 (1.00) CYP2A6ALDH1A1CYP3A4CYP1A2TP53
SCHEMBL120088 0.67 CYP2A6 (1.00) CYP2A6ALDH1A1CYP3A4CYP1A2TP53
SCHEMBL29419014 0.67 CYP2A6 (1.00) CYP2A6ALDH1A1CYP3A4CYP1A2TP53
SCHEMBL9983003 0.67 CYP2A6 (0.48) CYP2A6ALDH1A1CYP3A4CYP1A2CHRNB2
Phosphine SCHEMBL28126457 0.65 CYP2A6 (0.94) CYP2A6ALDH1A1CYP3A4CYP1A2TP53
Hydrochloric Acid SCHEMBL4831090 0.65 CYP2A6 (0.94) CYP2A6ALDH1A1CYP3A4CYP1A2TP53
SCHEMBL27812368 0.65 CYP2A6 (0.94) CYP2A6ALDH1A1CYP3A4CYP1A2TP53
SCHEMBL28301145 0.65 CYP2A6 (0.94) CYP2A6ALDH1A1CYP3A4CYP1A2TP53
SCHEMBL28275760 0.65 CYP2A6 (0.94) CYP2A6ALDH1A1CYP3A4CYP1A2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110319400-A1 PROKINETICIN 1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PAIN JANSSEN PHARMACEUTICA, NV (BE) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319400-A1 PROKINETICIN 1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PAIN PROKR1, OPRL1, PROKR2 CYP2A6 3711/4885ALDH1A1 1573/4885CYP3A4 4099/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.